DrugManagementForum.com

ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di

This is a discussion on ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di within the Biotechnology News forum, part of the Industry News and Updates category; > Targeted Genetics has bought out Sirna's share of a Huntington's disease program three years after the partnership ...


Go Back   DrugManagementForum.com > Industry News and Updates > Biotechnology News

ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di

Register Help Members List Mark Forums Read

Rate This Thread - ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di.

Only registered members can vote. To rate this thread register here.

Reply

 

Thread Tools
  #1 (permalink)  
Old 04-07-2008, 02:58 PM
automated news aggregator
  
Join Date: Jan 2008
Posts: 1,083
Default ALSO NOTED: Targeted Genetics buys Sirna's share of program; Indevus in $21M licensing deal;Atrium Innovations sells di
> Targeted Genetics has bought out Sirna's share of a Huntington's disease program three years after the partnership began. The deal follows Merck's buyout of Sirna at the end of last year. Read more...

More...
Reply With Quote
Reply

« Previous Thread | Next Thread »

Thread Tools
Display Modes
Linear Mode Linear Mode



© 2008 DrugManagementForum™ powered by
Informaceutica - Drug Management Information Company
Contact Us - Main Page - Site Map - Top

All times are GMT -4. The time now is 06:09 AM.